Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Islet Cell Transplantation After Kidney Transplantation
NCT03047200Phase 1Withdrawn
- Sponsor
- Baylor Scott & White Research Institute
- Start
- Jul 2008
- Primary completion
- Jan 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of islet transplantation in type 1 diabetes mellitus (T1D), sponsored by Baylor Scott & White Research Institute. Primary endpoint: Restoration of sustained euglycemia without exogenous insulin or with reduced insulin dosage at 24 months. Planned start Jul 2008; status: withdrawn.
02
Drugs
islet transplantation
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03047200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03047200.